Oral Anti-diabetic Drugs
First results from the phase III ALTTO trial (BIG 02-06; NCCTG 063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone.
Herceptin induced cardiotoxicity
SMi Group's 9th annual ADMET conference & exhibition
Non-pegylated liposomial doxorubicin is less cardiotoxic than epirubicin in women with breast cancer: evidence from the LITE randomized study Giuseppe.
The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall.
Giuseppe Biondi Zoccai, MD University of Modena and Reggio Emilia gbiondizoccai@gmail
